期刊文献+

DNA去甲基化药物研究现状 被引量:2

Status of researching DNA demethylation drug
下载PDF
导出
摘要 在肿瘤形成过程中,启动子区异常高甲基化的抑癌基因始终保持沉默、功能丧失,而启动子区去甲基化后抑癌基因则可以重新激活。因此,DNA去甲基化药物可治疗肿瘤。本文阐述了DNA甲基化与肿瘤的关系,以及DNA去甲基化药物的研究现状。 The promoter of exceptionally hypermethylation in tumor suppressor genes including key genes always kept silent and lost functions in the process of tumor formation.However,the tumor suppressor genes could be reactivated after the promoter region demethylation,which induce re-expression of tumor suppressor genes.Some of DNA demethylation drugs have been used in clinical treatment.The relationship between DNA methylation and tumor and the research of DNA demethylation drug is reviewed.
出处 《齐齐哈尔医学院学报》 2013年第4期559-561,共3页 Journal of Qiqihar Medical University
关键词 DNA甲基化 肿瘤 DNA去甲基化药物 DNA methylation tumor DNA demethylation drug
  • 相关文献

参考文献20

  • 1Yang B,Guo M,Herman J G, et al. Aberrant promoter methylation profiles of tumor suppressor genes in heaptocellular carcinoma. Am J Patho1,2003,163 ( 3 ) : 1101-1107.
  • 2Moltzer G, Vander Meulen MJ, Verheij H. Psychological characteristics of dissatisfied denture patients. Community Dent Oral Epidemiol, 1996,24:52-55.
  • 3Kaminskas E, Farrell AT, Wang YC, et al. FDA drug approval summary: azacitidine ( 5-azacytidine, Vidaza ) for injectable suspension. Oncologist,2005,10 ( 3 ) : 176-182.
  • 4Borthakur G,Ahdab SE,Ravandi F, et al. Activity of decitabine in patients with myelodys-plastic syndrome previously treated with azacitidine. Leuk Lymphoma,2008,49(4) :690-695.
  • 5Cheng JC, Weisenberger DJ, Gonzales FA, et al. Continuous zebularine treatment effeetively sustains demethylation in human bladder cancer ceils. Mol Ceil Biol ,2004 ,24 :1270-1278.
  • 6Segura-Pacheco 13, Trejo-Becerril C, Perez-Cdrdenas E, et at. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin Cancer Res,2003,9 (5) : 1596-1603.
  • 7Altundag O, Altundag K, Gunduz M. DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients. Med Hypotheses,2004,63 (4) :684-687.
  • 8Villar-Garea A, Fraga MF, Espada J, et al. Procaine is a DNA demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res,2003,63:4984-4989.
  • 9Deng C, Lu Q, Zheng Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. J Arthritis Rheum ,2003,48 (3) :746-756.
  • 10Song Y, Zhang C. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and reexpression. Cancer Chem other Pharm acol, 2009,63 ( 4 ) : 605- 613.

二级参考文献16

  • 1Ma X, Fang Y, Beklemisheva A, et al. Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells, Int J Oncol, 2006; 28(5) : 1287 -1293.
  • 2Herman JG, Graft JR, Myohanen, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996; 93(18) : 9821 -9826.
  • 3Spotswood HT, Tumer BM. An increasingly complex code. J Clin Invest, 2002 ; 110 ( 5 ) : R577 - R582.
  • 4Peterson CL, Laniel M. Histones and histone modifications. Curr Biol, 2004, 14(14) : 546 -551.
  • 5Jenuwein T. The epigenefic magic of histone lysine methylation. FEBS J, 2006; 273(14) : 3121 -3135.
  • 6Nakayama J, Rice JC, Strahl BD, et al. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science, 2001 ;292(5514) : 110 - 113.
  • 7Ogawa M, Sakashita K, Zhao XY, et al. Analysis of histone modification around the CpG island region of the p15 gene in acute myeloblastic leukemia. Leuk Res, 2007 ;31 (4) :611 - 621.
  • 8Tischoff I, Wittekind C, Tannapfel A. Role of epigenetic alterations in cholangiocarcinoma. J Hepatobiliary Pancreat Surg, 2006;13(4) : 274 -279.
  • 9Kondo Y, Shen L, Issa J P. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol,2003 ;23( 1 ) :206 -215.
  • 10Rush L J, Plass C. Alterations of DNA methylation in hematologic malignancies. Cancer Lett, 2002; 185( 1 ) : 1 - 12.

共引文献6

同被引文献19

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部